Literature DB >> 12472182

A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes).

Anne M Delles1, Kate Rittenhouse-Olson, Janet Morgan, Allan R Oseroff.   

Abstract

An adherence method was developed that enriches for antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes) from peripheral blood mononuclear cell (PBMC) preparations. This method utilizes the cells' natural adherence to polystyrene tissue culture dishes and their subsequent removal with K3EDTA after incubation at 4 degrees, with gentle pipeting. Flow cytometric analysis revealed that on average, the enrichment of CD83+ dendritic cells, CD14+ monocytes/ macrophages, and CD19+ B cells increased by 12.5 to 20, 2, and 4 fold, respectively, compared to their initial numbers present in PBMC preparations. Cell viability, determined by trypan blue exclusion, was between 90 and 98%. After the enrichment procedure, the cells could still be activated by tetanus toxoid and this was shown by flow cytometric analysis, as enhancement of class II major histocompatibility complex (MHC) (31% increase) (after antigen treatment). This is a fast and economical alternative to other established methods for the preparation of pure, functionally competent antigen presenting cells derived from peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472182     DOI: 10.1081/imm-120016243

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  6 in total

Review 1.  [Use of bone marrow mesenchymal stem cells for ex vivo cartilage regeneration].

Authors:  S Grässel; N Ahmed
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

2.  Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease.

Authors:  Kathryn A Arnold; John E Blair; Jonathan D Paul; Atman P Shah; Sandeep Nathan; Francis J Alenghat
Journal:  Exp Physiol       Date:  2019-07-25       Impact factor: 2.969

3.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

4.  Identification of compounds that decrease numbers of Mycobacteria in human macrophages in the presence of serum amyloid P.

Authors:  Wang Xiang; Nehemiah Cox; Richard H Gomer
Journal:  J Leukoc Biol       Date:  2017-08-02       Impact factor: 4.962

5.  Evaluation of immunomodulatory effects of Boswellia sacra essential oil on T-cells and dendritic cells.

Authors:  Alia M Aldahlawi; Amani T Alzahrani; Mohamed F Elshal
Journal:  BMC Complement Med Ther       Date:  2020-11-19

6.  Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.

Authors:  Lerisa Govender; Josip Mikulic; Jean-Christophe Wyss; Olivier Gaide; Margot Thome; Dela Golshayan
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.